Hyperopia and Myopia

3

Review clinical trials related to Hyperopia and Myopia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Eye Imaging for the Study of Childhood Myopia

Myopia (nearsightedness) is increasing worldwide and is becoming a serious public health problem. Studies estimate that by 2050, if no action is taken, almost half of the world's population will be myopic. About 10% of people could develop severe myopia, which increases the risk of serious eye problems such as retinal detachment, damage to the macula, or glaucoma. Children are particularly affected because myopia often worsens as they grow. Several treatments are now available to slow the progression of myopia in children, but these treatments are not equally effective for everyone. Some children respond better than others, and the reasons for these differences are not yet well understood. One possible explanation is that differences in eye anatomy may influence the effectiveness of a treatment. This suggests that myopia treatments may need to be tailored to each child. By studying the anatomy of the eye, researchers could improve and personalize myopia control strategies. The study entitled "Eye imaging for the study of childhood myopia" aims to better understand the structure of children's eyes. The study will collect clinical data, including images of the eye taken with MRI and measurements of the eye obtained using standard eye examination devices. The data will then be analyzed using image-processing and statistical methods to allow a detailed study of children's eye anatomy.

Participants needed: 100
Trial details
Age: 6-12Biological sex: AllType: InterventionalSponsor: Essilor InternationalUpdated: Mar 30, 2026Locations: 1
Eligibility criteria

Spherical equivalent under cycloplegia greater -6.5 D and less than 2 D [+2]

Declared neurological deficit, including history of epileptic pathology or senso... [+4]

Status: Recruiting

Algorithm-assisted Subjective Refraction Program Dedicated to Children

Current refraction assessment in children is dependent on the Eye Care Specialist and lacks standardization. Essilor has developed new algorithm assisted subjective refraction software dedicated to children of 6-12 years old and suitable for use with Vision-S™ and Vision-R™ phoropters, in addition to existing software. Two different versions of the software have been developed: the first incorporating only the steps needed to perform an entire subjective refraction process (vA), and the second, identical to the first but incorporating additional steps useful for managing the child's attention and cooperation (vB). The software performance in terms of subjective refraction results will be compared to a conventional subjective refraction method performed with the Vision-R™700 phoropter in manual mode.

Participants needed: 166
Trial details
Age: 6-12Biological sex: AllType: InterventionalSponsor: Essilor InternationalUpdated: Jul 1, 2025Locations: 1
Eligibility criteria

Age between 6 and 12 years [+5]

Vulnerability of the subject [+12]

Status: Recruiting

Evaluation of a New Laser Refractive Vision Correction Using the TENEO™ 317 Model 2

Prospective, post market clinical follow up study with a three months postoperative follow up to evaluate the visual and refractive outcomes of OCTAVIUS treatment when used as intended.

Participants needed: 81
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Bausch & Lomb GmbHUpdated: Jun 22, 2025Locations: 1
Eligibility criteria

Subjects already scheduled for bilateral refractive laser surgery targeting emme... [+12]

Subjects for whom the combination of their baseline corneal thickness and the pl... [+16]